Neurophysiological Study of tDCS Effects in Healthy Volunteers
tDCSHV
1 other identifier
interventional
18
1 country
1
Brief Summary
Transcranial direct current stimulation is a tool to modulate cortical excitability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1 healthy-volunteers
Started Nov 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 18, 2014
CompletedFirst Posted
Study publicly available on registry
April 29, 2014
CompletedMay 28, 2015
May 1, 2015
1 month
April 18, 2014
May 27, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Neurophysiological mesures changes
Modifications in neurophysiological test after direct current stimulation
up to 1 month
Other Outcomes (4)
VEP changes
up to 1 month
Blink changes
up to 1 month
CHEPS changes
up to 1 month
- +1 more other outcomes
Study Arms (1)
Cefaly tDCS
EXPERIMENTALCathodal Cefaly tDCS is delivered over the visual cortex at 2 mA of intensity, for 20 minutes, for 5 consecutive days in 9 HV. The anode is placed over the left DLPFC. 2 mA anodal tDCS is delivered over the visual cortex, for 20 minutes, for 5 consecutive days in 9 HV
Interventions
Cefaly tDCS (transcranial direct current stimulation) is able to modify cortical excitability, in particular anodal tDCS increases it. The side effects of tDCS are minor, especially sensations of itching and scalp paresthesias.
Eligibility Criteria
You may qualify if:
- healthy volunteers
You may not qualify if:
- age below 18 or above 65 years
- personal history of recurrent headache or other neurological diseases especially seizures,
- familial history of recurrent headache
- child migraine equivalents (motion sickness, cyclic vomiting or recurrent abdominal pain, somnambulism etc.. . .)
- chronic pain syndromes
- analgesics intake at the time of recording
- contra-indications to tDCS neurostimulation (metal prosthetics in the head or internal stimulation like a pacemaker).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Roberta Baschi
Liége, Liége, 4000, Belgium
Study Officials
- PRINCIPAL INVESTIGATOR
Delphine Magis, MD
University of Liege
- PRINCIPAL INVESTIGATOR
Jean Schoenen, MD
University of Liege
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Honorary Full Professor
Study Record Dates
First Submitted
April 18, 2014
First Posted
April 29, 2014
Study Start
November 1, 2013
Primary Completion
December 1, 2013
Study Completion
April 1, 2014
Last Updated
May 28, 2015
Record last verified: 2015-05